JPWO2005094885A1 - 慢性筋骨格痛を呈する疾患の予防および／または治療剤 - Google Patents

慢性筋骨格痛を呈する疾患の予防および／または治療剤 Download PDF

Info

Publication number
JPWO2005094885A1
JPWO2005094885A1 JP2006511707A JP2006511707A JPWO2005094885A1 JP WO2005094885 A1 JPWO2005094885 A1 JP WO2005094885A1 JP 2006511707 A JP2006511707 A JP 2006511707A JP 2006511707 A JP2006511707 A JP 2006511707A JP WO2005094885 A1 JPWO2005094885 A1 JP WO2005094885A1
Authority
JP
Japan
Prior art keywords
substituted
musculoskeletal pain
compound
therapeutic agent
chronic musculoskeletal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006511707A
Other languages
English (en)
Japanese (ja)
Inventor
廣 加瀬
廣 加瀬
勇美 ▲高▼橋
勇美 ▲高▼橋
俊二 九里
俊二 九里
小林　実
小林　　実
静男 塩崎
静男 塩崎
史郎 白倉
史郎 白倉
Original Assignee
協和醗酵工業株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 協和醗酵工業株式会社 filed Critical 協和醗酵工業株式会社
Publication of JPWO2005094885A1 publication Critical patent/JPWO2005094885A1/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
JP2006511707A 2004-03-30 2005-03-30 慢性筋骨格痛を呈する疾患の予防および／または治療剤 Withdrawn JPWO2005094885A1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004097422 2004-03-30
JP2004097422 2004-03-30
PCT/JP2005/006033 WO2005094885A1 (ja) 2004-03-30 2005-03-30 慢性筋骨格痛を呈する疾患の予防および／または治療剤

Publications (1)

Publication Number Publication Date
JPWO2005094885A1 true JPWO2005094885A1 (ja) 2007-08-16

Family

ID=35063534

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006511707A Withdrawn JPWO2005094885A1 (ja) 2004-03-30 2005-03-30 慢性筋骨格痛を呈する疾患の予防および／または治療剤

Country Status (5)

Country Link
US (1) US20070149555A1 (US20070149555A1-20070628-C00025.png)
EP (1) EP1738766A4 (US20070149555A1-20070628-C00025.png)
JP (1) JPWO2005094885A1 (US20070149555A1-20070628-C00025.png)
CA (1) CA2561383A1 (US20070149555A1-20070628-C00025.png)
WO (1) WO2005094885A1 (US20070149555A1-20070628-C00025.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811218B1 (fr) 2000-07-05 2003-02-28 Patrice Suslian Dispositif implantable destine a corriger l'incontinence urinaire
US20060205995A1 (en) 2000-10-12 2006-09-14 Gyne Ideas Limited Apparatus and method for treating female urinary incontinence
GB0025068D0 (en) 2000-10-12 2000-11-29 Browning Healthcare Ltd Apparatus and method for treating female urinary incontinence
US8167785B2 (en) 2000-10-12 2012-05-01 Coloplast A/S Urethral support system
GB0108088D0 (en) 2001-03-30 2001-05-23 Browning Healthcare Ltd Surgical implant
ATE487427T1 (de) 2002-08-02 2010-11-15 Bard Inc C R Selbstverankerndes schlingen- und einführsystem
GB0307082D0 (en) 2003-03-27 2003-04-30 Gyne Ideas Ltd Drug delivery device and method
GB0411360D0 (en) 2004-05-21 2004-06-23 Mpathy Medical Devices Ltd Implant
US9974636B2 (en) 2007-06-29 2018-05-22 Boston Scientific Scimed, Inc. Surgical articles and methods for treating pelvic conditions
TWI473614B (zh) * 2008-05-29 2015-02-21 Kyowa Hakko Kirin Co Ltd Anti-analgesic inhibitors
WO2020125779A1 (en) * 2018-12-21 2020-06-25 Sunshine Lake Pharma Co., Ltd. 8-substituted styryl xanthine derivatives and uses thereof
CN111072663B (zh) * 2019-12-12 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111018856B (zh) * 2019-12-12 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
DE69526822T2 (de) * 1994-02-23 2003-01-23 Kyowa Hakko Kogyo Kk Xanthin-derivate
US6117878A (en) * 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
US6232297B1 (en) * 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US6610324B2 (en) * 1999-04-07 2003-08-26 The Mclean Hospital Corporation Flupirtine in the treatment of fibromyalgia and related conditions
US6586413B2 (en) * 1999-11-05 2003-07-01 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
JP4128360B2 (ja) * 2000-04-26 2008-07-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 排便を促進する医薬組成物
AUPR606401A0 (en) * 2001-07-02 2001-07-26 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compound and pharmaceutical use thereof
JP2005510508A (ja) * 2001-11-08 2005-04-21 藤沢薬品工業株式会社 アデノシンアンタゴニストとしてのチアゾールピリダジノン類
AU2003237460A1 (en) * 2002-06-06 2003-12-22 Endacea, Inc. Combination treatments for purinoceptor-related disorders
AU2002950853A0 (en) * 2002-08-19 2002-09-12 Fujisawa Pharmaceutical Co., Ltd. Aminopyrimidine compound and pharmaceutical use thereof
MXPA05001461A (es) * 2002-08-30 2005-06-03 Kyowa Hakko Kogyo Kk Antagonistas del receptor a2a de adenosina para el tratamiento del sindrome de las piernas inquietas o trastornos relacionados.
UA79011C2 (uk) * 2002-09-05 2007-05-10 Гвіда Енд К. С.П.А. Одноразовий самонагрівний або самоохолоджуваний контейнер, переважно для напоїв, та спосіб його виготовлення

Also Published As

Publication number Publication date
CA2561383A1 (en) 2005-10-13
EP1738766A4 (en) 2010-05-12
US20070149555A1 (en) 2007-06-28
EP1738766A1 (en) 2007-01-03
WO2005094885A1 (ja) 2005-10-13

Similar Documents

Publication Publication Date Title
JPWO2005094885A1 (ja) 慢性筋骨格痛を呈する疾患の予防および／または治療剤
US8592420B2 (en) Method of treating an anxiety disorder
JP2015007096A (ja) 運動障害の予防および／または治療剤
JP2010511616A (ja) 水素化ピリド（４，３−ｂ）インドール（異性体）に基づいた認知機能および記憶を改善するための手段、当該手段に基づいた薬理学的手段、および当該手段の使用のための方法
EP1534289B1 (en) Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus
JP4648193B2 (ja) 医薬組成物
JP5188066B2 (ja) 薬物依存症の予防および／または治療剤
JP2006513207A (ja) 行動障害の治療のためのイストラデフィリン（ｋｗ−６００２）の使用
US7763625B2 (en) Agents for treating migraine
US20060205756A1 (en) Antitussives
EP1640007A1 (en) Antiepileptic agent
EP1234576A1 (en) Us0027324for eating disorders

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080311

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20101109